News
PEOPLE can exclusively announce that Alana "Honey Boo Boo" Thompson will reflect on the "darker side of child stardom" in ...
Sancomb wrapped up his junior season averaging north of 25 points, 10 rebounds and five assists, while leading the Maroon ...
Trump has long built his public and political persona around sporting events, and relishes turning up at live events to hear cheers from the crowd, even if some in attendance boo him. He also has ...
The new class of weight-loss medicines that has taken the world by a storm will now become available in India, with the pharmaceutical giant Eli Lilly on Thursday announcing the launch of tirzepatide ...
Eli Lilly and Company launched its weight loss drug Mounjaro in India on Thursday after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO). This is a drug which ...
“Semaglutide generics will be priced almost 95% lower than [Eli Lilly'] current price,” said Vishal Manchanda, senior vice-president, institutional research at Systematix Group. With the drop ...
The following is the full text of the March 20, 2025 address by former hostage Eli Sharabi at the UN Security Council in New York City. My name is Eli Sharabi. I am 53 years old. I’ve come ...
Tirzepatide was evaluated in two robust global clinical development programs. (Image Credits: Pexels) Eli Lilly and Company (India) on Thursday announced the launch of Mounjaro in single-dose vial ...
The much-awaited weightloss and diabetes drug, Mounjaro from US-based Eli Lilly and Company will be available at local chemists in a few weeks, at an India-specific price. Globally Mounjaro ...
Follow Bloomberg India on WhatsApp for exclusive content and analysis on what billionaires, businesses and markets are doing. Sign up here. Eli Lilly and Co. has begun selling its blockbuster ...
Eli Lilly stock has generated fantastic returns for investors over the past five years. The company possesses many lucrative growth opportunities to ensure it remains an excellent buy in the years ...
The session opened with testimony from Eli Sharabi, a survivor of Hamas captivity, who shared his account at a press conference and with the Council members during the session. "On October 7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results